Results 221 to 230 of about 6,372,774 (389)

A microRNA expression signature of human solid tumors defines cancer gene targets

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2006
S. Volinia   +17 more
semanticscholar   +1 more source

Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing

open access: yesMolecular Oncology, EarlyView.
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef   +10 more
wiley   +1 more source

Correction: Neuroradiological, genetic and clinical characteristics of histone H3 K27-mutant diffuse midline gliomas in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohort

open access: yesActa Neuropathologica Communications
Nobuhide Hayashi   +44 more
doaj   +1 more source

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.

open access: yesNew England Journal of Medicine, 2002
G. Demetri   +20 more
semanticscholar   +1 more source

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

open access: yesMolecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon   +13 more
wiley   +1 more source

Evaluation of Inflammatory Biomarkers in Parotid Tumors. [PDF]

open access: yesMed Sci Monit
Ikinciogullari A   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy